507264-66-6

Basic information

• Product Name: Carbamic acid, [1-(aminocarbonyl)cyclopropyl]-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, [1-(aminocarbonyl)cyclopropyl]-, 1,1-dimethylethyl ester (9CI);(1-Carbamoyl-cyclopropyl)-carbamic acid tert-butyl ester;tert-Butyl N-(1-carbamoylcyclopropyl)carbamate
• CAS NO: 507264-66-6
• Molecular Formula: C9H16N2O3
• Molecular Weight: 200.23494
• Product Categories: N-BOC
• Mol File: 507264-66-6.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Carbamic acid, [1-(aminocarbonyl)cyclopropyl]-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [1-(aminocarbonyl)cyclopropyl]-, 1,1-dimethylethyl ester (9CI)(507264-66-6)
• EPA Substance Registry System: Carbamic acid, [1-(aminocarbonyl)cyclopropyl]-, 1,1-dimethylethyl ester (9CI)(507264-66-6)

Safety Data

• Hazardous Substances Data: 507264-66-6(Hazardous Substances Data)

Upstream product

• 88950-64-5 1-<(tert-butyloxy)carbonylamino>cyclopropane-1-carboxylic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 137360-55-5 1-aminocyclopropane-1-carboxamide 

Relevant articles and documents

KV3 MODULATORS

A compound of formula (I) and related aspects.

INHIBITORS OF KEAP1-Nrf2 PROTEIN-PROTEIN INTERACTION

Sultam compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the KEAP1-Nrf2 interaction, such as inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

SUBSTITUTED 3-PHENYLQUINAZOLIN-4(3H)-ONES AND USES THEREOF

The present invention covers substituted 3-Phenylquinazolin-4(3H)-one compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of various inflammatory and fibrotic diseases of the respiratory tract and of the lungs as well as lung cancer, as a sole agent or in combination with other active ingredients.